The impact of early intervention using SGLT2i in Type 2 Diabetes

Webinar: The impact of early intervention using SGLT2i in Type 2 Diabetes.

Date: Wednesday 18th March

Time: 1pm - 2pm

Key takeaways:

• The importance of early intervention in T2D 
• The role of SGLT2i in T2D management and achieving a legacy effect Case study

Chair:

Minesh Parbat, PCPA Regional Vice-President, ICS Chief Pharmacist and Clinical Director Pharmacy and Medicines Optimisation, NHS Shropshire, Telford and Wrekin

Emann El-Abiary,

Clinical Pharmacist with Special Interest in Diabetes

Emann is a pharmacist with over 15 years of patient-focused experience across community and primary care. She began her primary care career as a minor ailments pharmacist and subsequently developed advanced clinical expertise across a wide range of long-term conditions, completing a Master’s degree in Advanced Clinical Practice (ACP). 

Emann has worked with diverse populations across multiple communities, gaining insight into varied patient demographics and healthcare needs. More recently, she has developed a specialist interest in diabetes, with a focus on improving outcomes for patients whose risks remain under-recognised and under-addressed, despite a growing evidence base supporting early intervention.